Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 5, 2012, Pages 398.e1-398.e8

  Caritis, Steve N ^a   Sharma, Shringi ^b   Venkataramanan, Raman ^b   Hankins, Gary D ^c   Miodovnik, Menachem ^d   Hebert, Mary F ^g   Umans, Jason G ^d,e,f   Benedetti, Thomas ^g   Mattison, Donald ^h   Zajicek, Anne ^h   Fischer, Dawn ^a   Jackson, Aimee ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e MEDSTAR RESEARCH INSTITUTE   (United States)

^f Delaware   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

cord blood; pharmacokinetics; placenta; preterm birth

Indexed keywords

HYDROXYPROGESTERONE CAPROATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY MASS; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; GESTATIONAL AGE; HUMAN; MATERNAL BLOOD; PLACENTAL TRANSFER; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; SINGLETON GESTATION; UMBILICAL CORD BLOOD;

EID: 84868156082     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.08.015     Document Type: Article

References (21)

1. P.J. Meis, M. Klebanoff, E. Thom Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate N Engl J Med 348 2003 2379 2385 Erratum in: N Engl J Med 349 2003 1299 (Pubitemid 36682816)
2. D.J. Rouse, S.N. Caritis, A.M. Peaceman A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins N Engl J Med 357 2007 454 461 (Pubitemid 47204874)
3. S.N. Caritis, D.J. Rouse, A.M. Peaceman Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial Obstet Gynecol 113 2009 285 292
4. W.A. Grobman Randomized controlled trial of progesterone treatment for preterm birth prevention in nulliparous women with cervical length less than 30 mm Am J Obstet Gynecol 206 suppl 2012 S367
5. American College of Obstetricians and Gynecologists ACOG committee opinion no. 419: use of progesterone to reduce preterm birth Obstet Gynecol 112 2008 963 965
6. S. Zhang, S.R. Mada, S. Sharma Simultaneous determination of 17-alpha hydroxyprogesterone caproate, 17-alpha hydroxyprogesterone and progesterone using high-performance liquid chromatography-mass spectrometric (HPLC-MS/MS) method in human plasma J Pharm Biomed Anal 48 2008 1174 1180
7. M. Onsrud, E. Paus, E. Huag, K. Kjorstak Intramuscular administration of hydroxyprogesterone caproate in patients with endometrial carcinoma Acta Obstet Gynecol Scand 64 1985 519 523 (Pubitemid 15241030)
8. S. Sharma, J. Ou, S. Strom, D. Mattison, S. Caritis, R. Venkataramanan Identification of enzymes involved in the metabolism of 17-hydroxyprogesterone caproate: an effective agent for prevention of preterm birth Drug Metab Dispos 36 2008 1896 1902
9. S. Caritis, S. Sharma, R. Venkataramanan Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation Am J Obstet Gynecol 205 2011 40.e1 40.e8
10. C. Cuppett, W. Zhao, S. Caritis, R. Venkataramanan Effect of endogenous steroids on 17 alpha-hydroxyprogesterone caproate (17-OHPC) metabolism Am J Obstet Gynecol 204 suppl 2011 S29
11. Y. Zhao, C. Cuppett, S. Caritis, R. Venkataramanan Effect of prescription medications on 17-alpha-hydroxyprogesterone caproate (17-OHPC) metabolism Am J Obstet Gynecol 206 suppl 2012 S9
12. S.J. Hemauer, R. Yan, S.L. Patrikeeva Transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate Am J Obstet Gynecol 199 2008 169.e1 169.e5
13. S. Sharma, E.C. Ellis, K. Dorko Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes Drug Metab Dispos 38 2010 723 727
14. V.M. Fokina, O.L. Zharikova, G.D. Hankins, M.S. Ahmed, T.N. Nanovskaya Metabolism of 17-alpha-hydroxyprogesterone caproate by human placental mitochondria Reprod Sci 19 2012 290 297
15. A.T. Northen, G.S. Norman, K. Anderson Follow-up of children exposed in utero to 17 -hydroxyprogesterone caproate compared with placebo Obstet Gynecol 110 2007 865 872 (Pubitemid 47508752)
16. T.R. Varma, J. Morsman Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy Int J Gynaecol Obstet 20 1982 137
17. J. Michaelis, H. Michaelis, E. Gluck, S. Keller Prospective studies of suspected association between certain drugs administered in early pregnancy and congenital malformations Teratology 27 1983 57
18. L.J. Resequie, J.F. Hick, J.A. Bruen, K.L. Noller, W.M. O'Fallon, L.T. Kurland Congenital malformations among offspring exposed in utero to progestins, Olmstead County, Minnesota 1936-1974 Fertil Steril 43 1985 514 519 (Pubitemid 15086699)
19. J.H. Check, A. Rankin, M. Teichman The risk of fetal anomalies as a result of progesterone therapy during pregnancy Fertil Steril 45 1986 575
20. Z. Katz, M. Lancet, J. Skornik, J. Chemke, B.M. Mogilner, M. Klinberg Teratogenicity of progestogens given during the first trimester of pregnancy Obstet Gynecol 65 1985 775 780 (Pubitemid 15051793)
21. P.A. Kester Effects of prenatally administered 17 alpha- hydroxyprogesterone caproate in adolescent males Arch Sex Behav 13 1984 441 455